AOP Health Announces U.S. Availability of Rapiblyk™ (landiolol) for...
- ICU
- 21/07/2025
AOP Health Announces U.S. Availability of Rapiblyk™ (landiolol) for Critical Care Use
READ MORE
AOP Health Announces U.S. Availability of Rapiblyk™ (landiolol) for Critical Care Use
READ MORE
RHEACELL and AOP Health: Strategic Partnership
READ MORE
Rare Diseases: How Drug Shortages Threaten Patients
READ MORE
Siemens Healthineers System Helps Cut Infection Rates at KRH Klinikum Siloah, Hannover
READ MORE
Hamilton Medical Unveils the HAMILTON-HF90 – A New Product Redefining High Flow Oxygen Therapy
READ MORE
From Invisibility to Insight: Data Unlocks New Potential in Rare Disease Research
READ MORE
Rare Disease Day 2025: New Podcast Series Supports Those Affected
READ MORE
Fresenius Medical Care Recognized in Dow Jones Sustainability World & Europe Indexes for 15th Time
READ MORE
U.S. FDA approves AOP Health’s Rapiblyk™
READ MORE
Fresenius Medical Care Awarded Agreement with Premier, Inc. for the Novalung® ECMO System
READ MORE